Unique ID issued by UMIN | UMIN000020069 |
---|---|
Receipt number | R000023184 |
Scientific Title | Comparison of Efficacy and Safety between Warfarin, Rivaroxaban and Edoxaban in patients with acute pulmonary embolism in showa university |
Date of disclosure of the study information | 2015/12/10 |
Last modified on | 2020/06/08 11:46:04 |
Comparison of Efficacy and Safety between Warfarin, Rivaroxaban and Edoxaban
in patients with acute pulmonary embolism in showa university
Edo-warivashi study in showa university
Comparison of Efficacy and Safety between Warfarin, Rivaroxaban and Edoxaban
in patients with acute pulmonary embolism in showa university
Edo-warivashi study in showa university
Japan |
Acute pulmonary embolism
Medicine in general | Cardiology | Intensive care medicine |
Others
NO
The purpose of this study are to compare efficacy and safety between Warfarin, Rivaroxaban and Edoxaban in patients with acute pulmonary embolism included severe conditions in showa university
Safety,Efficacy
Exploratory
Pragmatic
Not applicable
Score of Central Disease Score and
Thrombus volume in pulmonary vein measured by CT (if possible)
1)CT index score
2)Coagulation test
3)Change in UCG
4)Length of hospital stay and CCU
5)Length of disappearance of pulmonary embolism from an initial day
Interventional
Parallel
Randomized
Individual
Open -but assessor(s) are blinded
Active
NO
NO
Institution is not considered as adjustment factor.
NO
Pseudo-randomization
3
Treatment
Medicine |
Warfarin administration for 6 months with PTINR betweeen 2.00 and 3.00
Rivaroxaban administration at the dose of 15mg twice a day in the first 3 weeks.
Subsequently,Rivaroxaban administration at the dose of 15mg once a day for 6 months
Edoxaban administration at the dose of 60mg(30mg if the patients have the reduced criteria of Edoxaban) once a day for 6 months
20 | years-old | <= |
90 | years-old | >= |
Male and Female
Patients with acute pulmonary embolism who are and hospitalized in Showa University Hospital, Showa University Fujigaoka Hospital and Showa University Koto Toyosu Hospital and needed intensive care
CrCL less than 30ml/min
Patients with acute bleeding
Patients with active malignancy
Patients needed PCPS,IABP and aortic sheathes
Contraindication of each drug
100
1st name | |
Middle name | |
Last name | Norikazu Watanabe |
Department of Medicine,Showa university
Division of Cardiology
Division of Cardiology 1 tyoume 5 no 8 Hatanodai Shinagawaku Tokyo
0337848000
n-watanabe@med.showa-u.ac.jp
1st name | |
Middle name | |
Last name | Norikazu Watanabe Toigyu Matsui |
Department of Medicine Showa university
Division of Cardiology
Division of Cardiology 1 tyoume 5 no 8 Hatanodai Shinagawaku Tokyo
0337848000
n-watanabe@med.showa-u.ac.jp
Division of Cardiology, Department of Medicine,Showa university
Division of Cardiology, Department of Medicine,Showa university
Self funding
NO
昭和大学病院(東京都)・昭和大学藤が丘病院(神奈川県)・昭和大学江東豊洲病院(東京都)
Showa University Hospital・Showa University Fujigaoka Hospital・Showa University Koto Toyosu Hospital
2015 | Year | 12 | Month | 10 | Day |
Unpublished
Preinitiation
2015 | Year | 11 | Month | 27 | Day |
2015 | Year | 11 | Month | 28 | Day |
2015 | Year | 12 | Month | 10 | Day |
2018 | Year | 12 | Month | 10 | Day |
2019 | Year | 12 | Month | 10 | Day |
2019 | Year | 12 | Month | 10 | Day |
2019 | Year | 12 | Month | 10 | Day |
2015 | Year | 12 | Month | 04 | Day |
2020 | Year | 06 | Month | 08 | Day |
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000023184